Free Trial
NASDAQ:GELS

Gelteq Q2 2026 Earnings Results & Report

Gelteq logo
$0.42 +0.00 (+0.14%)
Closing price 11/11/2026 04:00 PM Eastern
Extended Trading
$0.42 +0.00 (+0.07%)
As of 07:35 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Gelteq reported Q2 2026 earnings on June 30, 2026. The company reported EPS of -$0.12.

Earnings Announcement Details

Quarter
Q2 2026
Report Date
Time
Before Market Opens

Gelteq EPS Results

Actual EPS
-$0.12
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Gelteq Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Conference Call Resources

Gelteq Q2 2026 Earnings FAQ

Gelteq (NASDAQ:GELS) reported earnings of -$0.12 per share for Q2 2026. The report was announced on Tuesday, June 30, 2026.

Gelteq Earnings Headlines

Gelteq Limited Reports Delay in Annual Filing
Could Gelteq’s (GELS) Gel Improve Oral Drug Delivery?
Why I'm selling my Snapback Indicator for just $7
For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indicator for a single $7 payment. Others previously paid $500. The indicator flashes a Crash Alert as a cue to exit or go short, and a Bull Run Alert as a cue to buy or go long. No strings attached, and Wood says there is an unusual reason behind the steep discount.tc pixel
See More Gelteq Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Gelteq? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Gelteq and other key companies, straight to your email.

About Gelteq

Gelteq (NASDAQ:GELS) is an Australia-based health and wellness company that develops oral delivery products using proprietary gel-based technology. Its platform is designed to deliver active ingredients through convenient oral formats and may be used in nutraceutical, pharmaceutical and consumer health applications.

The company focuses on the development and commercialization of products containing vitamins, supplements and other bioactive ingredients. Gelteq also works with partners and customers on product formulation and development, with the aim of improving convenience, taste and the delivery of active compounds compared with traditional dosage forms.

Gelteq was established in Australia and serves the health and wellness market through its product-development and delivery technology activities. The company’s shares trade on the Nasdaq Capital Market under the symbol GELS.

View Gelteq Profile